Gefitinib–cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies-Reference-Cited by-同舟云学术

Gefitinib–cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies

Published:2009-07-30 Issue:9 Volume:35 Page:1113-1120
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Phillip Lee Y.-H.,Sathigari Sateesh,Jean Lin Y.-J.,Ravis William R.,Chadha Gurkishan,Parsons Daniel L.,Rangari Vijay K.,Wright Nydeia,Babu R. Jayachandra

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03639040902783074

Reference22 articles.

1. Gefitinib, a novel, orally administered agent for the treatment of cancer

2. ‘Targeting’ the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa®) in non-small cell lung cancer (NSCLC)

3. Pharmacokinetics of gefitinib in humans: The influence of gastrointestinal factors

4. Current Knowledge and Future Directions of the Selective Epidermal Growth Factor Receptor Inhibitors Erlotinib (Tarceva®) and Gefitinib (Iressa®)

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion complexes of regorafenib with beta- and gamma-cyclodextrin derivatives: In silico and in vitro studies;Journal of Molecular Liquids;2024-10

2. Dissolution enhancement of Gefitinib by solid dispersion and complexation with β-cyclodextrins: In vitro testing, cytotoxic activity, and tablet formulation;Saudi Pharmaceutical Journal;2024-06

3. Gefitinib salts/cocrystals with phenolic acids as a promising solid-state approach to improve solubility;CrystEngComm;2024

4. Quality by design-assisted development of D-α-tocopherol polyethylene glycol 1000 succinate-incorporated gefitinib-loaded cationic liposome(s);Therapeutic Delivery;2023-12

5. Pentapeptide cRGDfK-Surface Engineered Nanostructured Lipid Carriers as an Efficient Tool for Targeted Delivery of Tyrosine Kinase Inhibitor for Battling Hepatocellular Carcinoma;International Journal of Nanomedicine;2023-11